Management of chronic kidney disease

image of Management of chronic kidney disease
Online Access: £ 25.00 + VAT
BSAVA Library Pass Buy a pass


For patients that develop chronic kidney disease, the underlying aetiology may never be identified. Irrespective of the inciting injury, the histopathological response to injury in the kidneys is the same, and tubulo-interstitial nephritis and fibrosis with variable degrees of secondary glomerulosclerosis and mineralization are usually identified. This chapter concerns itself with factors associated with progression of CKD, and treatment and management strategies for patients with CKD.

Preview this chapter:
Loading full text...

Full text loading...



Image of 23.2
23.2 Regulation of phosphorus in feline and canine patients with chronic kidney disease (CKD). IRIS = International Renal Interest Society.
Image of 23.4
23.4 The use of daily calcitriol therapy in dogs with IRIS CKD Stages 3 and 4. CKD = chronic kidney disease; IRIS = International Renal Interest Society; PTH = parathyroid hormone.
Image of 23.5
23.5 Management of proteinuria in dogs and cats with confirmed IRIS CKD Stages 1 to 3. ACEi = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; RAAS = renin–angiotensin–aldosterone system; SBP = systolic blood pressure; UPC = urine protein to creatinine ratio.
Image of 23.8
23.8 Flow diagram for the administration of darbepoetin in cats or dogs with chronic kidney disease. CBC = complete blood count; CKD = chronic kidney disease; PCV = packed cell volume; TP= total protein.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error